Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.7248
+0.172531.23%
Post-market: 0.75000.0252+3.48%19:59 EDT
Volume:5.42M
Turnover:3.67M
Market Cap:60.72M
PE:-0.24
High:0.7789
Open:0.5600
Low:0.5600
Close:0.5523
Loading ...
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2023

Major Issues Report

Form 8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 23, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 20, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report